248 related articles for article (PubMed ID: 27334757)
1. Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
Zeng Q; Wang Z; Liu C; Gong Z; Yang L; Jiang L; Ma Z; Qian Y; Yang Y; Kang H; Hong S; Bu Y; Hu G
Mol Cell Biochem; 2016 Jul; 418(1-2):137-46. PubMed ID: 27334757
[TBL] [Abstract][Full Text] [Related]
2. Silencing NFBD1/MDC1 enhances the radiosensitivity of human nasopharyngeal cancer CNE1 cells and results in tumor growth inhibition.
Wang Z; Zeng Q; Chen T; Liao K; Bu Y; Hong S; Hu G
Cell Death Dis; 2015 Aug; 6(8):e1849. PubMed ID: 26247734
[TBL] [Abstract][Full Text] [Related]
3. Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors.
Wang Z; Zuo W; Zeng Q; Qian Y; Li Y; Liu C; Wang J; Zhong S; Bu Y; Hu G
J Biomed Sci; 2019 Feb; 26(1):14. PubMed ID: 30717758
[TBL] [Abstract][Full Text] [Related]
4. Depletion of NFBD1/MDC1 Induces Apoptosis in Nasopharyngeal Carcinoma Cells Through the p53-ROS-Mitochondrial Pathway.
Wang Z; Liao K; Zuo W; Liu X; Qiu Z; Gong Z; Liu C; Zeng Q; Qian Y; Jiang L; Bu Y; Hong S; Hu G
Oncol Res; 2017 Jan; 25(1):123-136. PubMed ID: 28081741
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
[TBL] [Abstract][Full Text] [Related]
6. MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties.
Feng X; Zhang Q; Xia S; Xia B; Zhang Y; Deng X; Su W; Huang J
Mol Cells; 2014 Sep; 37(9):699-704. PubMed ID: 25245523
[TBL] [Abstract][Full Text] [Related]
7. O(6) -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma.
Chen SH; Kuo CC; Li CF; Cheung CH; Tsou TC; Chiang HC; Yang YN; Chang SL; Lin LC; Pan HY; Chang KY; Chang JY
Int J Cancer; 2015 Sep; 137(6):1291-305. PubMed ID: 25693518
[TBL] [Abstract][Full Text] [Related]
8. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
9. FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.
Song Y; Zhou X; Bai W; Ma X
Tumour Biol; 2015 Jun; 36(6):4197-202. PubMed ID: 25586348
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 1 promotes tumorigenesis and inhibits the sensitivity to 5-fluorouracil of nasopharyngeal carcinoma.
Song L; Liu H; Liu Q
Biomed Pharmacother; 2019 Oct; 118():109120. PubMed ID: 31302419
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
[TBL] [Abstract][Full Text] [Related]
12. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
13. O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinoma.
Chen SH; Huang WT; Kao WC; Hsiao SY; Pan HY; Fang CW; Shiue YL; Chou CL; Li CF
J Biomed Sci; 2021 Jan; 28(1):2. PubMed ID: 33397362
[TBL] [Abstract][Full Text] [Related]
14. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway.
Fang Y; Chai Z; Wang D; Kuang T; Wu W; Lou W
Mol Cell Biochem; 2015 Jan; 399(1-2):269-78. PubMed ID: 25348361
[TBL] [Abstract][Full Text] [Related]
15. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
[TBL] [Abstract][Full Text] [Related]
17. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
Pan Y; Zhou F; Zhang R; Claret FX
PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
[TBL] [Abstract][Full Text] [Related]
18. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma.
You Y; Yang W; Qin X; Wang F; Li H; Lin C; Li W; Gu C; Zhang Y; Ran Y
Cell Oncol (Dordr); 2015 Jun; 38(3):205-14. PubMed ID: 25707757
[TBL] [Abstract][Full Text] [Related]
19. CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma.
Lin J; Qin H; Han Y; Li X; Zhao Y; Zhai G
Drug Des Devel Ther; 2021; 15():323-330. PubMed ID: 33536745
[TBL] [Abstract][Full Text] [Related]
20. NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.
Feng S; Yang G; Yang H; Liang Z; Zhang R; Fan Y; Zhang G
Cell Cycle; 2017 May; 16(9):869-878. PubMed ID: 28379054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]